Cannabis Related Content
Beyond pain relief and mental health: The science behind CBD oil
Snoring? Dry skin? Sleeplessness? Eczema? Inflammation? Studies continue to explore the benefits of CBD oil, the cannabis plant extract.
Mile High Labs welcomes findings from cannabis report
Mile High Labs has announced support for the findings in a Centre for Medicinal Cannabis report.
The medicinal benefits of CBD oil and medical cannabis
Here we provide a brief introduction to the medical benefits of CBD and medical Cannabis, with an overview of treatments that have been implemented.
41% of Londoners would use CBD to manage their mental health
Research reveals Londoners are the most anxious and have the worst work-life balance in the UK and many would choose to use CBD oil rather than seeing their GP.
Five-year license issued to “Pharma Essenza Cannabis SA” and “PENTE SA”
A five-year license has been issued to two companies allowing the cultivation and processing of medical cannabis products.
Why cannabidiol really is the next big thing
From the stories appearing about CBD and its near miraculous effects, to the pharmaceutical companies rushing to catch up, it seems everyone is taking about cannabidiol.
We need to talk about access to medical cannabis
Ramya Sriram, manager at Kolabtree, explains why many patients in the UK still cannot access medical cannabis and how scientific communication and further research can lead to change.
Marijuana use during pregnancy: The cannabis conundrum
Dennis R. Carty, Ph.D. and Pamela J. Lein, Ph.D., University of California, highlight the rising trend of marijuana use during pregnancy and the implications surrounding it.
Medicinal cannabis requires further clinical research and educational support
Dr Mark Ware, Chief Medical Officer at Canopy Growth, provides an overview of the research that already exists around medicinal cannabis and explains why there is a need to educate clinicians further.
ECH announces plans to open first UK medical cannabis clinics
European Cannabis Holdings (ECH) has announced plans to open The Medical Cannabis Clinics in a step toward aiding patients living with a range of chronic conditions.
80% of people willing to ask doctor about medicinal cannabis
A survey by Rehab 4 Addiction using Facebook reveals more than 80% of people aged 55+ are contemplating asking their doctor about medicinal cannabis following the upcoming the change that’s due to kick in next week
Medicinal cannabis-based products to be made available on prescription
Home secretary, Sajid Javid has announced that medicinal products that derive from cannabis will be made available on prescription by Autumn.
Cannabis: One of the most thoroughly studied plants ever
David Bearman, M.D., Executive VP of the American Academy of Cannabinoid Medicine details the research priorities for cannabis, one of the most thoroughly studied plants of all time
How trusted data is helping to liberate the power of medical cannabis
Bradley Moore, CEO of GCAC discusses how artificial intelligence and blockchain (trusted data) solve the paradox of limited medical cannabis data and anecdotal user information
Cannabis developments in North America
Writer, medical cannabis patient, a grower and budtender for GrassRoots Medicinal in Squamish, Caleb McMillan, provides his thoughts on cannabis developments in North America today
Medical cannabis advocacy and education
Board Member for Canadians for Fair Access to Medical Marijuana (CFAMM), Peter Thurley, shares his views on medical cannabis advocacy and education issues
How blockchain could transform the cannabis industry
Rising blockchain technology could be a game changer for legal marijuana, according to small-cap cannabis stock Emerald Health Therapeutics
What is the European drug situation in 2017?
Jane Mounteney, Alexis Goosdeel and Paul Griffiths from the EMCDDA highlight key findings from the 2017 European Drug Report and new threats emerging.
